Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Apr;10(4):307-19.
doi: 10.1016/0166-0934(85)90047-3.

The agents of non-A, non-B viral hepatitis

D W Bradley

The agents of non-A, non-B viral hepatitis

D W Bradley. J Virol Methods. 1985 Apr.

Abstract

Recent studies have provided physicochemical and electron microscopic evidence for the existence of two distinct agents of posttransfusion non-A, non-B (NANB) hepatitis. One of these agents is chloroform-resistant and is not associated with the formation of unique ultrastructural structures in infected liver. The other agent is CHCl3-sensitive, induces the formation of characteristic hepatocyte cytoplasmic tubules, and interferes with concurrent HAV or HBV infection in experimentally inoculated chimpanzees. The tubuleforming agent (TFA) has also been shown to pass through an 80 nm capillary pore membrane filter, suggesting that it is a small enveloped (or lipid-containing) virus. The TFA can also be recovered from low titer (less than or equal to 10(5) infectious doses/ml) chronic-phase chimpanzee plasma by use of a multi-step purification procedure that assumes the agent is a small enveloped RNA virus with an approximate buoyant density of 1.24 g/cm3 and a sedimentation coefficient of 200-280 S. The apparent lack of nucleic acid homology between the NANB-TFA and HBV further suggests that the NANB-TFA is either Togavirus-like or belongs to another or as yet undefined class of RNA or DNA virus.

PubMed Disclaimer

References

    1. Aach R.D., Lander J.J., Miller W.V., Kahn R.A., Gitnick G.L., Hollinger R.B., Werch J., Szmuness W., Stevens C.E., Kellner A.K., Weiner J.M., Mosley J.W. In: Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention. Vyas G.N., Cohen S.N., Schmid R., editors. Franklin Institute Press; Philadelphia: 1978. p. 383.
    1. Alter H.J., Hoofnagle J.H. In: Viral Hepatitis and Liver Disease. Vyas G.N., Dienstag J.L., Hoofnagle J.H., editors. Grime and Stratton, Inc; New York: 1984. p. 345.
    1. Alter H.J., Purcell R.H., Holland P.V., Popper H. Lancet. 1978;1:459. - PubMed
    1. Alter H.J., Purcell R.H., Feinstone S.M., Tegtmeier G.E. In: Viral Hepatitis: 1981 International Symposium. Szmuness W., Alter H.J., Maynard J.E., editors. Franklin Institute Press; Philadelphia: 1982. p. 279.
    1. Bradley D.W. In: Advances in Hepatitis Research. Chisari F., editor. Masson Publishing U.S.A., Inc; New York: 1984. p. 268.